Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

EQL Pharma

EQL Pharma
2006 FOUNDED
PUBLIC STATUS
1-10 EMPLOYEES
EQL STOCK SYMBOL
$1.71 SHARE PRICE (As of Thursday Closing)
Description

EQL Pharma AB is a pharmaceutical company engaged in developing and selling medicines to pharmacies and hospitals. The products offered by the company include generics and parallel imports.

Ownership Status
Publicly Held
Financing Status
Corporation
Primary Industry
Pharmaceuticals
Stock Exchange
SAT
Primary Office
  • Traktorvagen 11
  • 226 60 Lund
  • Sweden

+46 046-12 00 00
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore EQL Pharma’s full profile, request a free trial.

EQL Pharma Stock Performance

52 wk Range Market Cap Prev. Close EPS Average Volume Shares
$1.10 - $1.75 $49M $1.69 13.6K 29.1M

EQL Pharma Financials Summary

In Thousands,
USD
TTM
31-Dec-2019
FY 2019
31-Mar-2019
FY 2018
31-Mar-2018
FY 2016
31-Dec-2016
Enterprise Value 40,100 37,680 33,656 24,145
Revenue 7,156 5,552 4,064 3,291
EBITDA 697 376 152 597
Net Income 160 (169) (62) 413
Total Assets 13,111 10,953 8,031 6,982
Total Debt 0 0 0 0
Public Fundamental Data provided by Morningstar, Inc. disclaimer

EQL Pharma Executive Team (1)

Name Title Board
Seat
Contact
Info
Christer Fåhraeus Ph.D Chief Executive Officer & President

EQL Pharma Board Members (1)

Name Representing Role Since Contact
Info
000000 0å00000 Self Board Member 000 0000